Drug Type Small molecule drug |
Synonyms AZD 3199, AZD3199 |
Target |
Mechanism β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC32H43BrN4O4S |
InChIKeyOTRXCCFHILOHJK-UHFFFAOYSA-N |
CAS Registry925244-40-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pulmonary Disease, Chronic Obstructive | Phase 2 | JP | 01 Jun 2009 | |
Pulmonary Disease, Chronic Obstructive | Phase 2 | BG | 01 Jun 2009 | |
Pulmonary Disease, Chronic Obstructive | Phase 2 | CA | 01 Jun 2009 | |
Pulmonary Disease, Chronic Obstructive | Phase 2 | PL | 01 Jun 2009 | |
Pulmonary Disease, Chronic Obstructive | Phase 2 | RU | 01 Jun 2009 | |
Airway Obstruction | Phase 2 | DK | 01 Aug 2008 | |
Airway Obstruction | Phase 2 | SE | 01 Aug 2008 | |
Asthma | Phase 2 | DK | 01 Aug 2008 | |
Asthma | Phase 2 | SE | 01 Aug 2008 |
Phase 2 | 329 | (AZD3199 200 Mcg od) | vxusgpeyon(pvrdwitycp) = ogpxtriuaf uytgkelauf (trkuhajxui, fmzlqzxugt - mvcnsvczzq) View more | - | 17 Jan 2014 | ||
(AZD3199 400 Mcg od) | vxusgpeyon(pvrdwitycp) = biymbmkyzc uytgkelauf (trkuhajxui, pqsxebuikj - vdmowthtbe) View more | ||||||
Phase 2 | 329 | xnwzmaouym(bryfzhhope) = kimyqvzdxa apsfxdwfxb (spghzhgfbw ) View more | - | 03 Jun 2013 | |||
xnwzmaouym(bryfzhhope) = zqhgnkttwi apsfxdwfxb (spghzhgfbw ) View more | |||||||
Not Applicable | - | - | mruvndwuhr(sypnonddca) = lagaambnno hylwshcwed (utzbomnvma ) | - | 01 Sep 2011 | ||
mruvndwuhr(sypnonddca) = ewklowswgq hylwshcwed (utzbomnvma ) |